Melissa M. Rowe

Internal Medicine

170 Governors Ave
Medford, MA 02155

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Addendum: Telomouse-a mouse model with human-length telomeres generated by a single amino acid change in RTEL1.

Addendum: Telomouse-a mouse model with human-length telomeres generated by a single amino acid change in RTEL1.

Journal: Nature communications

Published: May 01, 2026

Human length telomeres restrict the regenerative potential of hematopoietic stem cells in mice.

Human length telomeres restrict the regenerative potential of hematopoietic stem cells in mice.

Journal: The Journal of biological chemistry

Published: March 16, 2026

Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-deferred newly diagnosed multiple myeloma: Frailty subgroup analysis of CEPHEUS.

Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-deferred newly diagnosed multiple myeloma: Frailty subgroup analysis of CEPHEUS.

Journal: Leukemia

Published: February 19, 2026

Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma.

Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma.

Journal: Journal of medical economics

Published: February 17, 2026

Daratumumab in Transplant-Ineligible or -Deferred Newly Diagnosed Multiple Myeloma: Minimal Residual Disease in CEPHEUS.

Daratumumab in Transplant-Ineligible or -Deferred Newly Diagnosed Multiple Myeloma: Minimal Residual Disease in CEPHEUS.

Journal: Blood advances

Published: January 30, 2026

Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS.

Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS.

Journal: Blood advances

Published: January 30, 2026

A plain language summary of the CEPHEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for people with newly diagnosed multiple myeloma who are not expected to receive a stem cell transplant.

A plain language summary of the CEPHEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for people with newly diagnosed multiple myeloma who are not expected to receive a stem cell transplant.

Journal: Future oncology (London, England)

Published: October 08, 2025

Human length telomeres restrict the regenerative potential of hematopoietic stem cells in mice.

Human length telomeres restrict the regenerative potential of hematopoietic stem cells in mice.

Journal: bioRxiv : the preprint server for biology

Published: September 05, 2025

Daratumumab plus VRd in Japanese transplant-ineligible/deferred NDMM patients: Japanese subgroup of the CEPHEUS trial.

Daratumumab plus VRd in Japanese transplant-ineligible/deferred NDMM patients: Japanese subgroup of the CEPHEUS trial.

Journal: International journal of hematology

Published: July 18, 2025

Human-length Telomeres Limit Regeneration of Liver Epithelial Cells in Mice.

Human-length Telomeres Limit Regeneration of Liver Epithelial Cells in Mice.

Journal: Cellular and molecular gastroenterology and hepatology

Published: July 08, 2025

Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.

Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.

Journal: Blood

Published: May 29, 2025

Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.

Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.

Journal: Blood

Published: May 29, 2025

Showing 1-12 of 21

Last Updated: 09/26/2026